BPIQ Blog

Jan 4, 20235 min read

How does Lecanemab compare to other Alzheimer's assets?

Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...

Aug 8, 20221 min read

Biopharma Daily Pulse - 08/08/22

$XBI $93.89 | +1.72% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...

Aug 8, 20221 min read

Free Biopharma Daily Pulse - 08/08/22

$XBI $93.89 | +1.72% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...

Aug 8, 20221 min read

Biopharma Mid Morning Pulse - 08/08/22

(Posted 10:40am CST) $XBI $93.72 | +1.42% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Aug 8, 20221 min read

Free Biopharma Mid Morning Pulse - 08/08/22

(Posted 10:40am CST) $XBI $93.72 | +1.42% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Jul 29, 20221 min read

Biopharma Mid Morning Pulse - 07/29/22

(Posted 9:50am CST) $XBI $81.05 | -1.76% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Jul 29, 20221 min read

Free Biopharma Mid Morning Pulse - 07/29/22

(Posted 9:50am CST) $XBI $81.05 | -1.76% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Feb 4, 20221 min read

Biopharma Pulse - 1/31-2/4 Week in Review

As February begins, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity